Mobilaser Study to Help With People Who Are Having Problems With Their Gait

Early Phase 1

Completed

• Conditions: Parkinsonism; Parkinson's Disease
• Interventions: Device: Mobilaser

• Registration Number: NCT01581645
• Lead Sponsor: Mayo Clinic

Brief Summary

Does use of the Mobilaser reduce freezing of gait (FOG) and stride reduction in patients with Parkinson's disease and Parkinsonism.

Detailed Description

Can patients walk faster and have less freezing when using the mobilaser then when not using it

Study Timeline

• Study First Submitted: 2011-11-10
• Study First Submitted QC: 2012-04-19
• Study First Posted: 2012-04-20
• Study Start: 2012-05
• Primary Completion: 2013-12
• Study Completion: 2013-12
• Status Verified: 2015-04
• Last Update Submitted: 2015-12-30
• Last Update Posted: 2015-12-31

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 11

Inclusion Criteria

• Parkinsonian patients with Freezing of Gait or Gait hesitation.
• Must have evidence of bradykinesia ambulating (stride reduction or reduced arm swing)
• Must have a constant caregiver

Read More

Exclusion Criteria

• No cardiopulmonary contraindications to ambulation, e.g., unstable angina pectoris;
• Severe arthritis;
• Cerebellar or sensory ataxia;
• Recent knee or hip surgery

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Mobilaser	Mobilaser	Patients will begin by collecting data at home without using the mobilaser. They will then be given the mobilaser to use at home for 6 weeks while they collect data on whether their gait has improved. They will then have to return the Mobilaser to the clinic and collect data at home for 3 days to see if there is a difference.

Primary Outcome Measures

Name	Time	Method
Improvement in Gait	6 weeks

Trial Locations

Locations (1)

Mayo Clinic in Florida; 🇺🇸 Jacksonville, Florida, United States